A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment.
Hiroshi UreshinoYusuke TakedaKazuharu KamachiTakaaki OnoNoriyoshi IriyamaEiichi OhtsukaEmiko SakaidaShinya KimuraPublished in: Clinics and practice (2024)
The neutrophil-mediated immunomodulation can be a significant component for the effective achievement of TFR in CML supported by our clinical observation.